These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14723107)

  • 1. Dry eye moves beyond palliative therapy.
    Sheppard JD
    Manag Care; 2003 Dec; 12(12 Suppl):6-8. PubMed ID: 14723107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dry eye: prevalence, utilization, and economic implications.
    Dalzell MD
    Manag Care; 2003 Dec; 12(12 Suppl):9-13. PubMed ID: 14723108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation: a unifying theory for the origin of dry eye syndrome.
    Wilson SE
    Manag Care; 2003 Dec; 12(12 Suppl):14-9. PubMed ID: 14723109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiinflammatory therapy for dry eye.
    Pflugfelder SC
    Am J Ophthalmol; 2004 Feb; 137(2):337-42. PubMed ID: 14962426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations in the pharmacoeconomics of dry eye.
    Hirsch JD
    Manag Care; 2003 Dec; 12(12 Suppl):33-8. PubMed ID: 14723112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medications for dry eye syndrome: a drug-therapy review.
    Perry HD; Donnenfeld ED
    Manag Care; 2003 Dec; 12(12 Suppl):26-32. PubMed ID: 14723111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported compliance with topical cyclosporine emulsion 0.05% and onset of the effects of increased tear production as assessed through patient surveys.
    Trattler W; Katsev D; Kerney D
    Clin Ther; 2006 Nov; 28(11):1848-56. PubMed ID: 17213005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for the treatment of chronic dry eye disease.
    Sheppard JD
    Manag Care; 2003 Dec; 12(12 Suppl):20-5. PubMed ID: 14723110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
    Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
    Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
    Lee HK; Ryu IH; Seo KY; Hong S; Kim HC; Kim EK
    Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.
    Cordero-Coma M; Anzaar F; Sobrin L; Foster CS
    Ocul Immunol Inflamm; 2007; 15(2):99-104. PubMed ID: 17558834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ophthalmic cyclosporine (Restasis) for dry eye disease.
    Med Lett Drugs Ther; 2003 May; 45(1157):42-3. PubMed ID: 12766701
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinically important difference in dry eye: change in IDEEL-symptom bother.
    Fairchild CJ; Chalmers RL; Begley CG
    Optom Vis Sci; 2008 Aug; 85(8):699-707. PubMed ID: 18677226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dry eye syndrome in rheumatoid arthritis patients].
    Polanská V; Hlinomazová Z; Fojtík Z; Nemec P
    Cesk Slov Oftalmol; 2007 Nov; 63(6):422-30. PubMed ID: 18062166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of topical cyclosporine A emulsion 0.05% on the outcomes of patients with keratoconjunctivitis sicca.
    Stonecipher K; Perry HD; Gross RH; Kerney DL
    Curr Med Res Opin; 2005 Jul; 21(7):1057-63. PubMed ID: 16004673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responses to a dry eye questionnaire from a normal population.
    McMonnies CW; Ho A
    J Am Optom Assoc; 1987 Jul; 58(7):588-91. PubMed ID: 3668156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dry eye symptoms following cataract surgery.
    Roberts CW; Elie ER
    Insight; 2007; 32(1):14-21; quiz 22-3. PubMed ID: 17533782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding dry eye disease: a managed care perspective.
    Fiscella RG
    Am J Manag Care; 2011 Dec; 17 Suppl 16():S432-9. PubMed ID: 22435675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratoconjunctivitis sicca modifies epithelial stem cell proliferation kinetics in conjunctiva.
    Chen W; Zhao K; Li X; Yoshitomi T
    Cornea; 2007 Oct; 26(9):1101-6. PubMed ID: 17893543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of anti-inflammatory therapy on the treatment of dry eye syndrome].
    Mrukwa-Kominek E; Rogowska-Godela A; Gierek-Ciaciura S
    Klin Oczna; 2007; 109(1-3):79-84. PubMed ID: 17687921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.